iBio Corp - IBIO Net Assets per Single Share

Graphic logo of iBio, Inc. (IBIO)

iBio, Inc. (IBIO) is developing organic R&D, aiming for critical licenses with pharmaceutical behemoths. The book value per share, with GURU.Markets data illustrated on this chart, is rising, and the latest mark stands at 1.54. Business resilience is based on the RubrYc AI platform with closed patents, while human capital is secured by attracting top bioengineers through stock option programs.

iBio Inc (IBIO): Share Book Value from 07/04/2022 to 10/27/2026

ibioinc.com - analytical breakdowns and key metrics (IBIO)

- price and consensus price forecast:
Stock Price iBio Corp|IBIO - Analyst Median Target
- market capitalization data:
Market Value iBio, Inc.|IBIO - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share iBio|IBIO - Net Asset Value|Market Capitalization to Book Value Ratio ibioinc.com|IBIO - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital iBio, Inc.|IBIO - Long-Term Debt to Capital|Short-Term Debt to Equity iBio|IBIO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio iBio, Inc.
Fundamental company valuation:iBio Corp - IBIO
Manufactured products of iBio

For iBio, Inc., whose valuation relies on the intellectual property of the RubrYc platform, the current book value per share serves as an indicator of the business's material stability. This metric is calculated by dividing the total net assets by the number of shares outstanding, allowing investors to assess the company's intrinsic value and the risk of capital undervaluation relative to market quotes.

Competitors of iBio, Inc. (IBIO)

Book Value per Share ARGX (Argenx)|BNTX: Net Assets per Share|Net Assets per Single Share ABVX|ADMA (admabiologics.com) - Net Asset Value per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|Book Value per Share ATXS (Astria Pharma)|ENGN - Net Assets per Share|RAPT Therapeutics, Inc. (RAPT) - Book Value per Share|Aerovate Therapeutics (JBIO) - Net Assets per Single Share|ACRS: Book Value per Share|Net Assets per Share KYTX|Tiziana Life Sciences PLC - Net Assets per Single Share|Net Asset Value per Share Cabaletta Bio Inc CABA|Accounting Value per Share Ventyx Biosciences|Accounting Value of a Share theratech.com THTX|Book Value per Share AVTX (Avalo Therapeutics)|ELDN: Net Assets per Share|Net Assets per Single Share Agenus Inc|Climb Bio, Inc (CLYM) - Equity per Share|Book Value per Share ZURA|Accounting Value per Share atyrpharma.com (ATYR)|ADAG (Adagene) - Accounting Value per Share|Net Assets per Share ikenaoncology.com (IMA)|Book Value per Share STTK|Net Assets per Share Equillium Inc EQ|CNTB - Book Value per Share|IMUX - Net Assets per Single Share|atarabio.com - Book Value per Share|IFRX (InflaRx) - Net Assets per Share|Net Assets per Single Share XFOR (X4 Pharma)|Net Asset Value per Share ACET|CELU - Net Assets per Single Share|Share Book Value inmunebio.com (INMB)|Book Value per Share Barinthus Biotherapeutics plc|Accounting Value of a Share Kezar Life Sciences Inc. KZR|SAB Biotherapeutics, Inc - Book Value per Share|AKTX: Book Value per Share|Net Assets per Single Share enlivex.com ENLV|QTTB (Q32 Bio) - Accounting Value of a Share|Net Assets per Single Share GOVX|Accounting Value per Share Edesa Biotech Inc|Book Value per Share CARM|Book Value per Share XTL Bio XTLB|Accounting Value per Share Bolt Biotherapeutics, Inc.|Accounting Value of a Share HCW Biologics, Inc. HCWB|Book Value per Share APVO (Aptevo)|AIM: Net Assets per Share|ADTX (aditxt.com) - Net Assets per Single Share|GRI (GRI Bio Corporation) - Accounting Value per Share|Net Assets per Single Share XRTX|Accounting Value per Share reshapelifesciences.com (HIND)|Accounting Value per Share REVB|Book Value per Share INDP (Indaptus Therapeutics Inc)|SCNI - Net Assets per Single Share|Equity per Share CalciMedica Inc CALI|AFMD (Affimed Therapeutics) - Book Value per Share|ALLK - Net Asset Value per Share|hookipapharma.com - Book Value per Share|IGM Biosciences (IGMS) - Net Assets per Share|Book Value per Share iTeos|Net Assets per Single Share Ocean Biomedical Corp|TCBP (TC Biopharm) - Book Value per Share|Net Assets per Share THRD (thirdharmonicbio.com)